varespladib has been researched along with rvx 208 in 1 studies
| Studies (varespladib) | Trials (varespladib) | Recent Studies (post-2010) (varespladib) | Studies (rvx 208) | Trials (rvx 208) | Recent Studies (post-2010) (rvx 208) |
|---|---|---|---|---|---|
| 80 | 11 | 49 | 92 | 13 | 89 |
| Protein | Taxonomy | varespladib (IC50) | rvx 208 (IC50) |
|---|---|---|---|
| Bromodomain-containing protein 4 | Homo sapiens (human) | 1.629 | |
| Bromodomain-containing protein 2 | Homo sapiens (human) | 2.9935 | |
| Bromodomain-containing protein 3 | Homo sapiens (human) | 1.5467 | |
| Bromodomain testis-specific protein | Homo sapiens (human) | 2.8167 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inazu, A | 1 |
1 review(s) available for varespladib and rvx 208
| Article | Year |
|---|---|
[Novel therapy for atherosclerosis and inflammatory vascular disease].
Topics: Acetates; Amides; Apolipoprotein A-I; Atherosclerosis; Benzaldehydes; Blood Proteins; Cholesterol Ester Transfer Proteins; Clinical Trials as Topic; Drug Design; Esters; Humans; Indoles; Keto Acids; Molecular Targeted Therapy; Oxazolidinones; Oximes; Probucol; Quinazolines; Quinazolinones; Sulfhydryl Compounds | 2011 |